1. Home
  2. SNPX vs CNET Comparison

SNPX vs CNET Comparison

Compare SNPX & CNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNPX
  • CNET
  • Stock Information
  • Founded
  • SNPX 2012
  • CNET 2003
  • Country
  • SNPX United States
  • CNET China
  • Employees
  • SNPX N/A
  • CNET N/A
  • Industry
  • SNPX Medicinal Chemicals and Botanical Products
  • CNET Advertising
  • Sector
  • SNPX Health Care
  • CNET Consumer Discretionary
  • Exchange
  • SNPX Nasdaq
  • CNET Nasdaq
  • Market Cap
  • SNPX 3.9M
  • CNET 3.2M
  • IPO Year
  • SNPX N/A
  • CNET N/A
  • Fundamental
  • Price
  • SNPX $2.87
  • CNET $1.62
  • Analyst Decision
  • SNPX Strong Buy
  • CNET
  • Analyst Count
  • SNPX 1
  • CNET 0
  • Target Price
  • SNPX $14.00
  • CNET N/A
  • AVG Volume (30 Days)
  • SNPX 7.6K
  • CNET 9.5K
  • Earning Date
  • SNPX 03-31-2025
  • CNET 11-19-2024
  • Dividend Yield
  • SNPX N/A
  • CNET N/A
  • EPS Growth
  • SNPX N/A
  • CNET N/A
  • EPS
  • SNPX N/A
  • CNET N/A
  • Revenue
  • SNPX N/A
  • CNET $18,458,000.00
  • Revenue This Year
  • SNPX N/A
  • CNET N/A
  • Revenue Next Year
  • SNPX N/A
  • CNET N/A
  • P/E Ratio
  • SNPX N/A
  • CNET N/A
  • Revenue Growth
  • SNPX N/A
  • CNET N/A
  • 52 Week Low
  • SNPX $2.32
  • CNET $1.43
  • 52 Week High
  • SNPX $6.22
  • CNET $4.53
  • Technical
  • Relative Strength Index (RSI)
  • SNPX 42.62
  • CNET 45.28
  • Support Level
  • SNPX $2.82
  • CNET $1.56
  • Resistance Level
  • SNPX $3.00
  • CNET $1.64
  • Average True Range (ATR)
  • SNPX 0.18
  • CNET 0.04
  • MACD
  • SNPX -0.03
  • CNET 0.00
  • Stochastic Oscillator
  • SNPX 8.22
  • CNET 36.00

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

About CNET ZW Data Action Technologies Inc.

ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as the related data and technical services to small and medium enterprises in the PRC. It offers a variety channels of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of ecommerce O2O advertising and marketing services and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.

Share on Social Networks: